
Formats: [HTML](/news/2014/05/26/drugmaker-pfizer-says-it-will-not-proceed-with-its-attempted-119-billion-bid-for-astrazeneca.html)  [JSON](/news/2014/05/26/drugmaker-pfizer-says-it-will-not-proceed-with-its-attempted-119-billion-bid-for-astrazeneca.json)  [XML](/news/2014/05/26/drugmaker-pfizer-says-it-will-not-proceed-with-its-attempted-119-billion-bid-for-astrazeneca.xml)  

### [2014-05-26](/news/2014/05/26/index.md)

##### Pfizer
# Drugmaker Pfizer says it will not proceed with its attempted $119 billion bid for AstraZeneca. 




### Sources:

1. [AP via News 24](http://www.newshour24.com/business/1ze4asnccg/Ap-News-Alert.htm)

### Related:

1. [AstraZeneca rejects the latest, and likely the last, takeover price from Pfizer, close to 70 billion pounds or US$118 billion. ](/news/2014/05/19/astrazeneca-rejects-the-latest-and-likely-the-last-takeover-price-from-pfizer-close-to-70-billion-pounds-or-us-118-billion.md) _Context: AstraZeneca, Pfizer_
2. [Pharmaceutical company Pfizer discontinues research into treating patients with Alzheimer's disease and Parkinson's disease. [http:--www.telegraph.co.uk-science-2018-01-08-hunt-alzheimers-cure-suffers-heavy-blow-pfizer-pulls-research- "(The Telegraph)" ]](/news/2018/01/8/pharmaceutical-company-pfizer-discontinues-research-into-treating-patients-with-alzheimer-s-disease-and-parkinson-s-disease-http-www-tel.md) _Context: Pfizer_
3. [Because of a nationwide shortage of intravenous sodium bicarbonate (i.e., baking soda solution), United States hospitals are rationing its use in heart surgery, chemotherapy, for patients whose blood is too acidic, and as an antidote to certain poisons. The two primary producers, Amphastar and Pfizer, indicate that supplies will not increase until late June. ](/news/2017/05/22/because-of-a-nationwide-shortage-of-intravenous-sodium-bicarbonate-i-e-baking-soda-solution-united-states-hospitals-are-rationing-its-u.md) _Context: Pfizer_
4. [Pfizer Inc. decides to terminate its $160 billion merger with Allergan, Plc as officials in Washington crack down on corporate inversions. Pfizer will need to pay a $400 million fee to Allergan for expenses relating to the deal. ](/news/2016/04/5/pfizer-inc-decides-to-terminate-its-160-billion-merger-with-allergan-plc-as-officials-in-washington-crack-down-on-corporate-inversions-p.md) _Context: Pfizer_
5. [The U.S. Treasury Department announces new regulations to curb tax-avoiding corporate inversions, i.e., where U.S. companies slash their tax bills by claiming a new tax home overseas, though their core operations and management remain in the United States. The pending $160 billion merger of Pfizer Inc. and Allergan, Plc could be cancelled because of these new rules. ](/news/2016/04/4/the-u-s-treasury-department-announces-new-regulations-to-curb-tax-avoiding-corporate-inversions-i-e-where-u-s-companies-slash-their-tax.md) _Context: Pfizer_
